Skip to main content

$760M For Illinois In Opioid Settlement

$760M For Illinois In Opioid Settlement

$760M For Illinois In Opioid Settlement

Introduction

The state attorney general of Illinois announced that the state would receive $760 million from the pharmaceutical distributors as part of the opioid settlement for their role in the drug crisis.

The state would get the amount from the national opioid settlement of $26 billion. The funds are expected to be transferred to states and local governments as early as April. The maximum amount of the funds would be used by the state to conduct programs related to prevention and recovery from opioid addiction.

Nearly all the Illinois counties have signed the agreement along with 104 municipalities. A state panel will determine the individual payments of the local governments by considering the shipped amount of opioids, population, overdose deaths and opioid usage rates.

The deal was announced last year and has been finalized earlier this week after a majority of the local and state governments signed it. The funds would soon be transferred to the respective governments to deal with the pandemic.           

The United States has witnessed more than 500,000 opioid-related deaths over the last two decades. The death rate has increased during the coronavirus pandemic as more than 76,000 people died of using opioids in 12 months until April 2021.

The $26 billion national opioid settlement includes funds from drugmaker Johnson & Johnson (J&J) along with three major drug distributors of the U.S namely AmerisourceBergen, Cardinal Health and McKesson. J&J will pay a share of $5 billion, and the remaining amount of $21 billion would be paid by the distributors.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Attorneys Seek Reconsideration of Talc MDL Daubert Ruling

Categories: General

Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…

Philips resolves DreamStation suits for $1.1B

Categories: Settlements

Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…

FDA OKs Generic OTC Naloxone Spray Approved by FDA

Categories: FDA Related

The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.

Our Legal Drafting Services    
start @ $25 per hour.